Envestnet Portfolio Solutions’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Buy |
3,273
+645
| +25% | +$81.1K | ﹤0.01% | 1188 |
|
|
2025
Q1 | $291K | Sell |
2,628
-240
| -8% | -$26.5K | ﹤0.01% | 1302 |
|
|
2024
Q4 | $391K | Buy |
2,868
+278
| +11% | +$37.9K | ﹤0.01% | 1356 |
|
|
2024
Q3 | $298K | Sell |
2,590
-120
| -4% | -$13.8K | ﹤0.01% | 1456 |
|
|
2024
Q2 | $373K | Buy |
2,710
+168
| +7% | +$23.1K | ﹤0.01% | 1260 |
|
|
2024
Q1 | $351K | Buy |
2,542
+12
| +0.5% | +$1.66K | ﹤0.01% | 1277 |
|
|
2023
Q4 | $333K | Buy |
2,530
+78
| +3% | +$10.3K | ﹤0.01% | 1237 |
|
|
2023
Q3 | $276K | Buy |
+2,452
| New | +$276K | ﹤0.01% | 1269 |
|